Open access · US-GOV
via ClinicalTrials.gov Clinical trial
The Efficacy and Safety of Chinese Herbal Compound Yijing Keli in the Treatment of Ovarian Aging: A Multicenter and Prospective Study.
Authors not listed
Tongji Hospital · 2021
Abstract
Ovarian aging (OA) seriously affects the physical and mental health of women. Nowadays, Chinese herbs have huge appeal and potential in treating OA. We have created a new Chinese herbal combination Yijing Keli, whereas its safety and efficacy still need to be validated. Hence, we will perform a population-based, multicenter study to confirm the safety and efficacy of Yijing Keli in therapy of OA. We aim to provide a solid evidence for TCM in therapy of OA.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-03 MST
Cite this
APA
Anonymous. (2021). The Efficacy and Safety of Chinese Herbal Compound Yijing Keli in the Treatment of Ovarian Aging: A Multicenter and Prospective Study. <em>Tongji Hospital</em>. https://clinicaltrials.gov/study/NCT06271928
Vancouver
Anonymous. The Efficacy and Safety of Chinese Herbal Compound Yijing Keli in the Treatment of Ovarian Aging: A Multicenter and Prospective Study. Tongji Hospital. 2021.
BibTeX
@misc{anon2021TheEff,
title = {The Efficacy and Safety of Chinese Herbal Compound Yijing Keli in the Treatment of Ovarian Aging: A Multicenter and Prospective Study.},
author = {Anonymous},
journal = {Tongji Hospital},
year = {2021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University of Colorado, Boulder 2011
Open access · US-GOV
Clinical Translation of Nitrite Therapy to Treat Arterial Aging in Humans
University of Florida 2014
Open access · US-GOV
Efficacy of Fermented Papaya Preparation on Markers of Systemic Inflammation
Johns Hopkins Bloomberg School of Public Health 2018
Open access · US-GOV
Aging and Cognitive Health Evaluation in Elders (ACHIEVE) Randomized Trial
Innovation in aging 2024
Open access · OA
BIOMARKERS OF AGING AND PRECISION HEALTH CARE FOR OLDER ADULTS
BioAge Labs, Inc. 2021
Open access · US-GOV
A Phase 2a, 12-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of BGE-117 in the Treatment of Anemia of Aging
Örebro University, Sweden 2020
Open access · US-GOV